ArticleObesity surgery2026
Challenges in Cardiac Risk Stratification for Bariatric Surgery: A Single-Centre Experience.
Article in Obesity surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPreoperative cardiac risk stratification in patients undergoing bariatric surgery is challenged by suboptimal transthoracic echocardiography (ECHO) due to high body mass index (BMI). In this retrospective study, we described the diagnostic yield of technetium-99 m tetrofosmin single-photon emission computed tomography (SPECT) or Myoview compared with ECHO and characterised the potential contribution of imaging-derived information to preoperative decision-making.
methodsRetrospective cohort of 66 adults were evaluated for bariatric surgery who underwent SPECT and/or ECHO between 2017 and 2024. Imaging findings, agreement between modalities, downstream angiographic testing and surgical outcomes were analysed using correlation, Bland-Altman plot, χ², and logistic regression.
resultsCardiometabolic burden was high (hypertension 60.9%, OSA 57.8%, diabetes 56.3%; coronary artery disease (CAD) 16.7%). Thirty-five (53.0%) underwent surgery. ECHO was attempted in 45/66 (68.2%); image quality was limited in 20/45 (44.4%). SPECT showed reversible ischemia in 13 (19.7%), fixed in 8 (12.1%), and no ischemia in 45 (68.2%). Known CAD was associated with abnormal SPECT (χ²=11.338, p = 0.023). Overall ejection fraction (EF) agreement between ECHO and SPECT was poor among the 40 patients with paired EF measurements.
conclusionIn our high-risk bariatric cohort, ECHO was often limited by image quality, while SPECT provided additional perfusion and gated functional data. However, the retrospective design, single-centre setting, small sample size, lack of a comparator pathway, and very low event rate preclude conclusions regarding clinical utility, safety, superiority, or outcome benefit. These findings support further prospective evaluation of SPECT high-risk bariatric patients to better define its role within the preoperative cardiac assessment pathway.
Indexed as
Identifiers
42474953What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.